FDA limits use of GSK-Vir's sotrovimab for Covid-19

The US FDA has updated the EUA Fact Sheet limiting the usage of GSK and Vir's sotrovimab for Covid-19, due to the BA.2 Omicron sub-variant.

Related Keywords

New York ,United States ,Puerto Rico ,Maine ,New Hampshire ,New Jersey ,United Kingdom ,Massachusetts ,Virgin Islands ,Vermont ,Rhode Island ,Connecticut , ,Montgomery County Planning Commission Flickr Creative Commons ,European Commission ,Drug Administration ,Regulatory Agency ,Laboratory Informatics ,Strategic Business Technology Consulting ,Staffing Services ,Crystallisation Solutions For Pharmaceutical Companies ,Montgomery County Planning Commission ,Creative Commons ,Emergency Use Authorization ,Fact Sheet ,Vir Biotechnology ,United Kingdom Medicines ,Pharmaceutical Technology ,Strategic Business ,Technology Consulting ,